BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38342438)

  • 1. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.
    Moja L; Zanichelli V; Mertz D; Gandra S; Cappello B; Cooke GS; Chuki P; Harbarth S; Pulcini C; Mendelson M; Tacconelli E; Ombajo LA; Chitatanga R; Zeng M; Imi M; Elias C; Ashorn P; Marata A; Paulin S; Muller A; Aidara-Kane A; Wi TE; Were WM; Tayler E; Figueras A; Da Silva CP; Van Weezenbeek C; Magrini N; Sharland M; Huttner B; Loeb M
    Clin Microbiol Infect; 2024 Apr; 30 Suppl 2():S1-S51. PubMed ID: 38342438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries.
    Hsia Y; Lee BR; Versporten A; Yang Y; Bielicki J; Jackson C; Newland J; Goossens H; Magrini N; Sharland M;
    Lancet Glob Health; 2019 Jul; 7(7):e861-e871. PubMed ID: 31200888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe.
    Budd E; Cramp E; Sharland M; Hand K; Howard P; Wilson P; Wilcox M; Muller-Pebody B; Hopkins S
    J Antimicrob Chemother; 2019 Nov; 74(11):3384-3389. PubMed ID: 31361000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.
    Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA
    Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of access, watch, and reserve (AWaRe) group of antibiotics in community pharmacies located close to a tertiary care hospital in Lalitpur, Nepal.
    Jha N; Thapa B; Pathak SB; Kafle S; Mudvari A; Shankar PR
    PLoS One; 2023; 18(11):e0294644. PubMed ID: 37983218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries.
    Pauwels I; Versporten A; Drapier N; Vlieghe E; Goossens H;
    J Antimicrob Chemother; 2021 May; 76(6):1614-1624. PubMed ID: 33822971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WHO essential medicines list AWaRe book: from a list to a quality improvement system.
    Sharland M; Zanichelli V; Ombajo LA; Bazira J; Cappello B; Chitatanga R; Chuki P; Gandra S; Getahun H; Harbarth S; Loeb M; Mendelson M; Moja L; Pulcini C; Sati H; Tacconelli E; Zeng M; Huttner B
    Clin Microbiol Infect; 2022 Dec; 28(12):1533-1535. PubMed ID: 36007869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of prescribing patterns of antibiotics using National Treatment Guidelines and World Health Organization prescribing indicators at the Ghana Police Hospital: a pilot study.
    Darkwah TO; Afriyie DK; Sneddon J; Cockburn A; Opare-Addo MNA; Tagoe B; Amponsah SK
    Pan Afr Med J; 2021; 39():222. PubMed ID: 34630834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of antibiotic prescribing patterns at dental and primary health care clinics according to WHO Access, Watch, Reserve (AWaRe) classification.
    Alshareef H; Alanazi A; Alatawi N; Eleshmawy N; Ali M
    Am J Infect Control; 2023 Mar; 51(3):289-294. PubMed ID: 35870657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries.
    Bortone B; Jackson C; Hsia Y; Bielicki J; Magrini N; Sharland M
    PLoS One; 2021; 16(1):e0241899. PubMed ID: 33471786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year trends of antibiotic prescribing in surgery departments of two private sector hospitals in Central India: a prospective observational study.
    Skender K; Machowska A; Dhakaita SK; Lundborg CS; Sharma M
    BMC Public Health; 2024 Jan; 24(1):310. PubMed ID: 38281052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review.
    Rashed AN; Jackson C; Gastine S; Hsia Y; Bielicki J; Standing JF; Tomlin S; Sharland M
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1099-1106. PubMed ID: 31760892
    [No Abstract]   [Full Text] [Related]  

  • 14. Vigilance Needed in Treating Leprosy Patients in Accordance with WHO's AWaRe.
    Thangaraju P; Velmurugan H; Yella SST; Venkatesan S
    Recent Adv Antiinfect Drug Discov; 2022; 17(2):95-102. PubMed ID: 35864797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
    Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R
    Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool.
    Sharland M; Gandra S; Huttner B; Moja L; Pulcini C; Zeng M; Mendelson M; Cappello B; Cooke G; Magrini N;
    Lancet Infect Dis; 2019 Dec; 19(12):1278-1280. PubMed ID: 31782385
    [No Abstract]   [Full Text] [Related]  

  • 18. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ground level utility of Access, Watch, Reserve classification: Insights from a tertiary care center in North India.
    Negi G; Kb A; Panda PK
    World J Exp Med; 2023 Dec; 13(5):123-133. PubMed ID: 38173545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
    Holloway KA; Rosella L; Henry D
    PLoS One; 2016; 11(3):e0152020. PubMed ID: 27002977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.